| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antiphospholipid antibodies in response to infection
|
Avčin, Tadej
|
|
|
9 |
3 |
p. 212-218
|
artikel
|
| 2 |
Antiphospholipid antibodies in response to infection
|
Avčin, Tadej
|
|
2007
|
9 |
3 |
p. 212-218
|
artikel
|
| 3 |
Antiphospholipid antibody effects on monocytes
|
Wolberg, Alisa S.
|
|
|
9 |
3 |
p. 198-204
|
artikel
|
| 4 |
Antiphospholipid antibody effects on monocytes
|
Wolberg, Alisa S.
|
|
2007
|
9 |
3 |
p. 198-204
|
artikel
|
| 5 |
Clinical trials report
|
Hennigan, Stephanie
|
|
|
9 |
3 |
p. 229-230
|
artikel
|
| 6 |
Clinical trials report
|
O’Neil, Kathleen M.
|
|
2007
|
9 |
3 |
p. 187-189
|
artikel
|
| 7 |
Clinical trials report
|
Hennigan, Stephanie
|
|
2007
|
9 |
3 |
p. 229-230
|
artikel
|
| 8 |
Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?
|
Clark, Erin A. S.
|
|
|
9 |
3 |
p. 219-225
|
artikel
|
| 9 |
Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?
|
Clark, Erin A. S.
|
|
2007
|
9 |
3 |
p. 219-225
|
artikel
|
| 10 |
Genetic factors in the pathogenesis of CPPD crystal deposition disease
|
Couto, Ana Rita
|
|
|
9 |
3 |
p. 231-236
|
artikel
|
| 11 |
Genetic factors in the pathogenesis of CPPD crystal deposition disease
|
Couto, Ana Rita
|
|
2007
|
9 |
3 |
p. 231-236
|
artikel
|
| 12 |
Macrovascular involvement in systemic sclerosis: Comorbidity or accelerated atherosclerosis?
|
Blagojevic, Jelena
|
|
2007
|
9 |
3 |
p. 181-182
|
artikel
|
| 13 |
Mechanisms of aPL-mediated thrombosis: Effects of aPL on endothelium and platelets
|
Vega-Ostertag, Mariano E.
|
|
|
9 |
3 |
p. 190-197
|
artikel
|
| 14 |
Mechanisms of aPL-mediated thrombosis: Effects of aPL on endothelium and platelets
|
Vega-Ostertag, Mariano E.
|
|
2007
|
9 |
3 |
p. 190-197
|
artikel
|
| 15 |
Recent developments in crystal-induced inflammation pathogenesis and management
|
Lioté, Frédéric
|
|
|
9 |
3 |
p. 243-250
|
artikel
|
| 16 |
Recent developments in crystal-induced inflammation pathogenesis and management
|
Lioté, Frédéric
|
|
2007
|
9 |
3 |
p. 243-250
|
artikel
|
| 17 |
Role of complement in antiphospholipid antibody-mediated thrombosis
|
O’Neil, Kathleen M.
|
|
|
9 |
3 |
p. 205-211
|
artikel
|
| 18 |
Role of complement in antiphospholipid antibody-mediated thrombosis
|
O’Neil, Kathleen M.
|
|
2007
|
9 |
3 |
p. 205-211
|
artikel
|
| 19 |
Tumoral calcinosis: New insights for the rheumatologist into a familial crystal deposition disease
|
Sprecher, Eli
|
|
|
9 |
3 |
p. 237-242
|
artikel
|
| 20 |
Tumoral calcinosis: New insights for the rheumatologist into a familial crystal deposition disease
|
Sprecher, Eli
|
|
2007
|
9 |
3 |
p. 237-242
|
artikel
|
| 21 |
Uric acid nephrolithiasis
|
Liebman, Scott E.
|
|
|
9 |
3 |
p. 251-257
|
artikel
|
| 22 |
Uric acid nephrolithiasis
|
Liebman, Scott E.
|
|
2007
|
9 |
3 |
p. 251-257
|
artikel
|
| 23 |
Uricase and other novel agents for the management of patients with treatment-failure gout
|
Sundy, John S.
|
|
|
9 |
3 |
p. 258-264
|
artikel
|
| 24 |
Uricase and other novel agents for the management of patients with treatment-failure gout
|
Sundy, John S.
|
|
2007
|
9 |
3 |
p. 258-264
|
artikel
|
| 25 |
Web alert
|
|
|
2007
|
9 |
3 |
p. 183-184
|
artikel
|
Tijdschrift beschrijving